论文部分内容阅读
随着强烈化疗和骨髓移植的进展 ,中青年急性髓性白血病(ＡＭＬ)的完全缓解率和长期无病生存率不断提高[1] ,而在老年人ＡＭＬ的疗效仍不满意 ,且老年ＡＭＬ的发病率呈增加趋势 ,因此老年人ＡＭＬ的治疗已成为一个令人关注的问题。我们总结了我院 2 1例老年ＡＭＬ患者在不同剂量
With the progress of intensive chemotherapy and bone marrow transplantation, the complete remission rate and long-term disease-free survival rate of middle-aged and young acute myeloid leukemia (AML) continue to increase [1], while the efficacy of AML in the elderly is still not satisfactory, and elderly AML The incidence rate is increasing, so the treatment of elderly AML has become a concern. We summarized the different doses of 21 elderly patients with AML in our hospital.